- By Sarah Campian, MS, CGC
- Posted April 16, 2026
Leading the Shift to Proactive Care: The Christ Hospital’s High‑Risk Program Strategy
In the traditional healthcare model, cancer care is often reactive—a race against time that begins only after a diagnosis. But at The Christ Hospital Health Network, the goal is to flip that script. Under the leadership of Dr. Kevin Banks, Executive Director of Precision Health and Pharmacogenomics, the network is turning their focus to identifying…
- By Frankie Fann, MS, CGC
- Posted April 9, 2026
A Hidden Cancer, Found in Time: One Patient’s CARE Journey
Germline genetic testing, also known as hereditary cancer testing, can reveal inherited risks for certain cancers long before symptoms appear. For many patients, this knowledge opens the door to proactive screening and early detection, when cancers may be easier to treat. By routinely assessing which patients may be at increased hereditary risk,…
- By Frankie Fann, MS, CGC
- Posted March 25, 2026
The CARE Difference: A Smarter Workflow for High‑Risk Screening
Patients with elevated cancer risks are often unidentified within healthcare systems for a variety of reasons, including fragmented workflows and limited access to cancer risk assessment tools. Danielle Rogers recently shared her experience with providing personalized assessments of cancer risks before and after implementation of the Ambry CARE…
- By Cassidy Janis, MS, CGC
- Posted March 11, 2026
Making Waves with MAVES
From Uncertainty… Cassidy: When I met with my patient in late 2021, she had already faced bilateral breast cancer. First at age 52, and again in the other breast at age 55. In terms of family history, she only had a brother who was diagnosed with brain cancer and testicular cancer, so her family history didn’t indicate there was a strong…
- By Shabnam Asgari, MS, CGC
- Posted November 4, 2025
The Gene Scene: PALB2
Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications.These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…
- By Caroline Elsas, MS, CGC
- Posted October 22, 2025
Progeny Research Spotlight: Uncovering Breast Cancer Risk in the GYN Oncology Clinic
Dr. Melissa Frey, a gynecologic oncologist, cancer geneticist, and researcher based in New York City—is redefining what gynecologic (GYN) cancer survivorship can look like. In our last blog featuring Dr. Frey’s research, we explored how her clinic transformed family history collection and risk assessment using Progeny. At first, Dr. Frey…
- By Heather Fecteau, MS, CGC
- Posted September 24, 2025
Unlocking Personalized Breast Care: The Role of Breast Density
Since September 10, 2024, every mammogram facility in the U.S. is required to provide patients with a clear summary of their breast density—bringing awareness of this important factor front and center.1 While breast density significantly influences risk, it’s only one piece of a larger puzzle. To improve early detection and deliver truly…
- By Lisa McGuire, MBA, BSBM
- Posted July 16, 2025
Creating Program Champions: The Power of Staff Education and Ownership in Our High-Risk Women's Program
When we partnered with Ambry to launch our High-Risk Women's Program (HRWP) at HCA Florida Ocala in 2023, I was excited about the potential to improve early cancer detection and even prevention in our mammography patients. The Ambry CARE Program® (CARE) provided the digital tools we needed to assess hereditary and breast cancer risk based on…
- By Robert Pilarski, MS, LGC
- Posted June 26, 2025
Building Trust in Digital Screening: Validating CARE’s Hereditary Cancer Risk Assessment
As a certified genetic counselor who spent eleven years on the National Comprehensive Cancer Network® (NCCN®)'s committee for the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for breast, ovarian, and pancreatic cancers, I've witnessed firsthand the challenges clinicians face in accurately identifying patients who meet criteria…
- By Lisa McGuire, MBA, BSBM
- Posted June 4, 2025
Personalized Care in Action: The Unexpected Discovery That Validated Our High-Risk Program
As the Director of Oncology at HCA Florida Ocala, I've witnessed firsthand how the combination of innovative technology and dedicated healthcare teams can transform patient outcomes. When we launched our high-risk women's program in 2023, I served as project manager, coordinating the implementation of the Ambry CARE Program® (CARE) across our…